10-K: Balchem Corporation Details Securities Registered Under the 1934 Exchange Act in Form 10-K Filing
Annual Report
Balchem Corporation's Form 10-K filing details the company's securities registered under Section 12 of the Securities Exchange Act of 1934, primarily its common stock.
Summary
- Balchem Corporation's Form 10-K filing describes its common stock, par value $0.06-2/3 per share, as the class of securities registered under Section 12 of the Securities Exchange Act of 1934.
- The document summarizes key aspects of the common stock, referencing the company's charter, bylaws, and Maryland General Corporation Law.
- Balchem is authorized to issue up to 122,000,000 shares of stock, including 120,000,000 shares of common stock and 2,000,000 shares of preferred stock, par value $25.00 per share.
- The board of directors is authorized to issue shares of stock or securities convertible into shares of stock without stockholder approval, including preferred stock in one or more series.
- Common stockholders are entitled to receive dividends, share ratably in assets upon liquidation, and have one vote per share on all matters submitted to a vote.
- The document also outlines provisions related to business combinations, control share acquisitions, director nominations, and liability limitations for directors and officers.
- The aggregate market value of the common stock held by non-affiliates as of June 30, 2023, was approximately $4,321,000,000.
- As of February 2, 2024, there were 32,266,941 shares of common stock outstanding.
Sentiment
Score: 6
Explanation: The document is neutral in tone, providing factual information about the company's securities and governance. It does not express any positive or negative sentiment but is essential for investors to understand the company's structure and potential risks.
Positives
- The company has the flexibility to issue additional shares of stock and classify unissued shares of preferred stock, providing increased options for future financings and acquisitions.
- Common stockholders have the right to receive dividends and share in assets upon liquidation.
- The company's charter contains a provision limiting the liability of its directors and officers to the maximum extent permitted by Maryland law.
- The bylaws obligate the company to indemnify its present and former directors and officers to the maximum extent permitted by Maryland law.
Negatives
- The issuance of additional shares of stock could dilute voting and other stockholder rights.
- Rights to receive dividends on common stock may be limited by the terms of any future classified and issued shares of preferred stock.
- Certain provisions of the charter and bylaws and of Maryland law could delay, defer, or prevent a change in control of the company.
Risks
- The board of directors' authority to issue preferred stock without stockholder approval could have the effect of delaying, deferring, or preventing a change in control of the company.
- The absence of preemptive rights for stockholders means that the company may issue additional shares of stock that may reduce their proportionate voting and financial interest.
- Business combinations with interested stockholders are prohibited for five years after the date on which the interested stockholder became an interested stockholder.
- The company may redeem for fair value any or all of the control shares if voting rights are not approved at a meeting or if the acquiring person does not deliver an acquiring person statement.
Future Outlook
The company believes that the power to issue additional shares of stock and to classify unissued shares of preferred stock provides increased flexibility in structuring possible future financings and acquisitions and in meeting other needs which might arise.
Industry Context
This announcement is a standard regulatory filing (Form 10-K) detailing the company's capital structure and governance, which is common for publicly traded companies. It does not directly relate to specific industry trends or competitors but provides essential information for investors to assess the company's financial position and potential risks.
Comparison to Industry Standards
- The capital structure and governance provisions described in the document are typical for publicly traded companies in the United States.
- The authorized share capital and the board's authority to issue preferred stock are common features designed to provide flexibility in corporate finance and defense against hostile takeovers.
- Comparable companies like DuPont, Dow, and BASF also have similar provisions in their charters and bylaws.
- The limitations on director liability and indemnification are standard practices to attract and retain qualified individuals to serve on the board.
- The specific details of these provisions, such as the par value of shares and the super-majority vote requirements, can vary among companies but serve similar purposes.
Stakeholder Impact
- Shareholders: The document provides information relevant to their voting rights, potential dilution, and participation in company profits.
- Employees: The document outlines provisions related to stock options and other equity-based compensation, impacting their potential financial benefits.
- Potential Investors: The document provides key information for assessing the company's capital structure, governance, and potential risks, aiding in investment decisions.
Key Dates
| Date | Description |
|---|---|
| 1934 | Securities Exchange Act of 1934, which governs the registration of Balchem's securities. |
| June 30, 2023 | Date used to calculate the aggregate market value of the common stock held by non-affiliates. |
| February 2, 2024 | Date for the number of shares outstanding of common stock. |
Keywords
common stock, preferred stock, securities, board of directors, stockholders, charter, bylaws, Maryland General Corporation Law, dividends, voting rights, liquidation, business combinations, control share acquisitions, director nominations, liability limitations, indemnification
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.